Company / EPS (Diluted)
Decoy Therapeutics Inc. EPS (Diluted) History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$7.72
FY2022
5-year range
-$7.72 / -$0.50
FY2018-FY2022
Trend
-1444.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -1444% YoY in FY2022, a notable deviation from the 6-year average annual change of -227%.
Based on SEC 10-K filings.
-7.72 in FY2022.
Declined from $-2.12 to $-7.72 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, eps (diluted) decreased 1444.0% year-over-year.
- Peak eps (diluted) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$7.72 | -1444.0% |
| FY2021 | -$0.50 | +76.4% |
| FY2020 | -$2.12 | -82.8% |
| FY2019 | -$1.16 | +52.3% |
| FY2018 | -$2.43 | -16.8% |
| FY2017 | -$2.08 | +54.5% |
| FY2016 | -$4.57 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026